{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:32:43Z","timestamp":1760099563602},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T00:00:00Z","timestamp":1091664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00432-004-0588-1","type":"journal-article","created":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T11:39:53Z","timestamp":1091619593000},"page":"649-656","source":"Crossref","is-referenced-by-count":26,"title":["The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I\/123I-MIBG as predictors for radionuclide therapy"],"prefix":"10.1007","volume":"130","author":[{"given":"Zairong","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Biersack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Ezziddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timur","family":"Logvinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,8,5]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/bjc.1994.224","volume":"69","author":"Abdelmoumene","year":"1994","unstructured":"Abdelmoumene N, Schlumberger M, Gardet P, Roche A, Travagli JP, Francese C, Parmentier C (1994) Selective venous sampling catheterization for localization of persisting medullary thyroid carcinoma. Br J Cancer 69:1141?1144","journal-title":"Br J Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s002590050296","volume":"25","author":"Adams","year":"1998","unstructured":"Adams S, Baum RP, Hertel A, Schumm-Draeger PM, Usadel KH, Hor G (1998) Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med 25:1277?1283","journal-title":"Eur J Nucl Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00003072-200108000-00004","volume":"26","author":"Arslan","year":"2001","unstructured":"Arslan N, Ilgan S, Yuksel D, Serdengecti M, Bulakbasi N, Ugur O, Ozguven MA (2001) Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery. Clin Nucl Med 26:683?688","journal-title":"Clin Nucl Med"},{"key":"CR4","first-page":"912","volume":"37","author":"Baudin","year":"1996","unstructured":"Baudin E, Lumbroso J, Schlumberger M, Leclere J, Giammarile F, Gardet P, Roche A, Travagli JP, Parmentier C (1996) Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med 37:912?916","journal-title":"J Nucl Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0039-6109(16)44183-6","volume":"67","author":"Brunt","year":"1987","unstructured":"Brunt LM, Wells SA Jr (1987) Advances in the diagnosis and treatment of medullary thyroid carcinoma. Surg Clin North Am 67:263?279","journal-title":"Surg Clin North Am"},{"key":"CR6","first-page":"617","volume":"43","author":"de","year":"2002","unstructured":"de Jong M, Krenning E (2002) New advances in peptide receptor radionuclide therapy. J Nucl Med 43:617?619","journal-title":"J Nucl Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ajcp\/70.4.587","volume":"70","author":"DeLellis","year":"1978","unstructured":"DeLellis RA, Rule AH, Spiler I, Nathanson L, Tashjian AH Jr, Wolfe HJ (1978) Calcitonin and carcinoembryonic antigen as tumour markers in medullary thyroid carcinoma. Am J Clin Pathol 70:587?594","journal-title":"Am J Clin Pathol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s002590100614","volume":"28","author":"Diehl","year":"2001","unstructured":"Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, Lange H, Bredow J, Korber C, Grunwald F (2001) Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 28:1671?1676","journal-title":"Eur J Nucl Med"},{"key":"CR9","first-page":"264","volume":"40","author":"Dralle","year":"1992","unstructured":"Dralle H, Damm I, Scheumann GF, Kotzerke J, Kupsch E (1992) Frequency and significance of cervicomediastinal lymph node metastases in medullary thyroid carcinoma: results of a compartment-oriented microdissection method. Henry Ford Hosp Med J 40:264?267","journal-title":"Henry Ford Hosp Med J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/thy.1992.2.113","volume":"2","author":"Frank-Raue","year":"1992","unstructured":"Frank-Raue K, Raue F, Buhr HJ, Baldauf G, Lorenz D, Ziegler R (1992) Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 2:113?117","journal-title":"Thyroid"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1677\/joe.0.1520275","volume":"152","author":"Hanna","year":"1997","unstructured":"Hanna FWF, Ardill JES, Johnston CF, Cunningham RT, Curry WJ, Russell CF, Buchanan KD (1997) Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. J Endocrinol 152:275?281","journal-title":"J Endocrinol"},{"key":"CR12","first-page":"561","volume":"21","author":"Hoefnagel","year":"1994","unstructured":"Hoefnagel CA (1994) Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med 21:561?581","journal-title":"Eur J Nucl Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","volume":"83","author":"Hundahl","year":"1998","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report of 53,856 cases of thyroid carcinomas treated in the U.S.\u00a01985?1995. Cancer 83:2638?2648","journal-title":"Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jcem.86.2.7194","volume":"86","author":"Kaltsas","year":"2001","unstructured":"Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL, Reznek R, Monson JP, Besser GM, Foley R, Britton KE, Grossman AB (2001) Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86:895?902","journal-title":"J Clin Endocrinol Metab"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003072-199904000-00008","volume":"24","author":"Krausz","year":"1999","unstructured":"Krausz Y, Rosler A, Guttmann H, Ish-Shalom S, Shibley N, Chisin R, Glaser B (1999) Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid. Clin Nucl Med 24:256?260","journal-title":"Clin Nucl Med"},{"key":"CR16","first-page":"1907","volume":"39","author":"Kurtaran","year":"1998","unstructured":"Kurtaran A, Scheuba C, Kaserer K, Schima W, Czerny C, Angelberger P, Niederle B, Virgolini I (1998) Indium-111-DTPA-D-Phe1-octreotide and technetium-99m (V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma. J Nucl Med 39:1907?1909","journal-title":"J Nucl Med"},{"key":"CR17","first-page":"1413","volume":"76","author":"Kwekkeboom","year":"1993","unstructured":"Kwekkeboom DJ, Reubi JC, Lamberts SW, Bruining HA, Mulder AH, Oei HY, Krenning EP (1993) In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab 76:1413?1417","journal-title":"J Clin Endocrinol Metab"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s002590100574","volume":"28","author":"Kwekkeboom","year":"2001","unstructured":"Kwekkeboom DJ, Bakker WH, Kooij PPM, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP (2001) [177Lu-DOTA0, Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients. Eur J Nucl Med 28:1319?1325","journal-title":"Eur J Nucl Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02988565","volume":"8","author":"Lupoli","year":"1991","unstructured":"Lupoli G, Lombardi G, Panza N, Biondi B, Pacilio G, Lastoria S, Salvatore M (1991) 131I-meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma. Med Oncol Tumor Pharmacother 8:7?13","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1114::AID-CNCR23>3.0.CO;2-4","volume":"78","author":"Lupoli","year":"1996","unstructured":"Lupoli G, Cascone E, Arlotta F, Vitale G, Celentano L, Salvatore M, Lombardi G (1996) Treatment of advanced medullary thyroid carcinoma with a combination of recombination interferon alpha-2b and octreotide. Cancer 78:1114?1118","journal-title":"Cancer"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/thy.1995.5.407","volume":"5","author":"Marsh","year":"1995","unstructured":"Marsh DJ, Learoyd DL, Robinson BG (1995) Medullary thyroid carcinoma: recent advances and management update. Thyroid 5:407?424","journal-title":"Thyroid"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00001622-199801000-00010","volume":"10","author":"Oeberg","year":"1998","unstructured":"Oeberg K (1998) Advances in chemotherapy and biotherapy of endocrine tumors. Curr Opin Oncol 10:58?65","journal-title":"Curr Opin Oncol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1507\/endocrj1954.33.309","volume":"33","author":"Oishi","year":"1986","unstructured":"Oishi S, Sasaki M, Sato T, Hirota Y, Takahashi M (1986) Imaging and uptake mechanism of 131I-meta-iodobenzylguanidin in medullary thyroid carcinoma. Endocrinol Jpn 33:309?315","journal-title":"Endocrinol Jpn"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03347169","volume":"10","author":"Oosterom","year":"1987","unstructured":"Oosterom R, Verleun T, Bruining HA, Hackeng WH, Lamberts SW (1987) Human medullary thyroid carcinoma in tissue culture: secretion of calcitonin and carcinoembryonic antigen. J Endocrinol Invest 10:117?121","journal-title":"J Endocrinol Invest"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0039-6060(05)80097-2","volume":"118","author":"O","year":"1995","unstructured":"O?Riordain DS, O?Brien T, Crotty TB, Gharib H, Grant CS, van Heerden JA (1995) Multiple endocrine neoplasia type 2b: more than an endocrine disorder. Surgery 118:936?942","journal-title":"Surgery"},{"key":"CR26","first-page":"641","volume":"Endocrinol","author":"Papotti","year":"2001","unstructured":"Papotti M, Kumar U, Volante M, Pecchioni C, Patel YC (2001) Immunohistochemical detection of somatostatin receptor types 1?5 in medullary carcinoma of the thyroid. Clin Endocrinol (Oxf) 54:641?649","journal-title":"Clin"},{"key":"CR27","first-page":"31","volume":"21","author":"Raue","year":"1989","unstructured":"Raue F, Winter J, Frank-Raue K, Lorenz D, Herfarth C, Ziegler R (1989) Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma. Horm Metab Res Suppl 21:31?34","journal-title":"Horm Metab Res Suppl"},{"key":"CR28","first-page":"273","volume":"25","author":"Rufini","year":"2000","unstructured":"Rufini V, Salvatori M, Garganese MC, Di Giuda D, Lodovica Maussier M, Troncone L (2000) Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma. Rays 25:273?282","journal-title":"Rays"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00006231-199207000-00006","volume":"13","author":"Solanki","year":"1992","unstructured":"Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13:513?521","journal-title":"Nucl Med Commun"},{"key":"CR30","first-page":"66","volume":"43","author":"Szakall","year":"2002","unstructured":"Szakall S Jr, Esik O, Bajzik G, Repa I, Dabasi G, Sinkovics I, Agoston P, Tron L (2002) 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med 43:66?71","journal-title":"J Nucl Med"},{"key":"CR31","first-page":"1823","volume":"17","author":"Troncone","year":"1997","unstructured":"Troncone L, Rufini V (1997) 131I-MIBG therapy of neural crest tumors. Anticancer Res 17:1823?1832","journal-title":"Anticancer Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00006231-200106000-00011","volume":"22","author":"Waldherr","year":"2001","unstructured":"Waldherr C, Schumacher T, Pless M, Crazzolara A, Maecke HR, Nitzsche EU, Haldemann A, Mueller-Brand J (2001) Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using [90Y]-DOTA-D-Phe1-Tyr3-octrotide: a pilot study. Nucl Med Commun 22:673?678","journal-title":"Nucl Med Commun"},{"key":"CR33","first-page":"610","volume":"43","author":"Waldherr","year":"2002","unstructured":"Waldherr C, Pless M, Maecke HR, Schumacher T, Crazzolara A, Nitzsche EU, Haldemann A, Mueller-Brand J (2002) Tumor response and clinical benefit in neuroendocrine tumors after 7.4\u00a0GBq 90Y-DOTATOC. J Nucl Med 43:610?616","journal-title":"J Nucl Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archotol.125.8.842","volume":"125","author":"Wang","year":"1999","unstructured":"Wang Q, Takashima S, Fukuda H, Takayama F, Kobayashi S, Sone S (1999) Detection of medullary thyroid carcinoma and regional lymph node metastases by magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 125:842?848","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-004-0588-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-004-0588-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-004-0588-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T04:01:23Z","timestamp":1682740883000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-004-0588-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,5]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1007\/s00432-004-0588-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,5]]}}}